Which imaging modality was used to guide the decision to administer thrombolytic therapy in the stroke scenario?

Which imaging modality was used to guide the decision to administer thrombolytic therapy in the stroke scenario?

• A. MRI
• B. CT
• C. Ultrasound
• D. X-ray

Answer: (A)

In the hyperacute stroke setting, the imaging goal is to decide quickly whether giving a thrombolytic is safe and likely beneficial. The key is to rule out a brain bleed and other contraindications, because a thrombolytic can cause catastrophic hemorrhage if a bleed is present. Non-contrast CT of the head is used first because it is fast, widely available, and excellent at detecting acute intracranial hemorrhage. If no bleed is seen and there are no contraindications, thrombolysis can proceed within the approved time window. MRI can provide more sensitive information about early brain injury and can map tissue viability with diffusion and perfusion imaging. In selected cases—such as when the onset time is uncertain, in wake-up strokes, or when CT results are inconclusive—MRI can help refine treatment decisions. However, it typically requires more time and resources, which can delay therapy in the emergency setting, so it is not the standard modality used to guide thrombolysis in most acute protocols. Ultrasound and X-ray don’t provide the necessary rapid, whole-brain assessment needed to guide thrombolytic therapy decisions in acute stroke. Ultrasound mainly adds vascular information and is not used alone to decide about thrombolysis, and X-ray offers limited brain detail relevant to this decision. So, while MRI has important roles in comprehensive stroke evaluation, the standard imaging choice to guide thrombolysis in the acute window is non-contrast CT, with MRI used selectively in specific scenarios.

In the hyperacute stroke setting, the imaging goal is to decide quickly whether giving a thrombolytic is safe and likely beneficial. The key is to rule out a brain bleed and other contraindications, because a thrombolytic can cause catastrophic hemorrhage if a bleed is present. Non-contrast CT of the head is used first because it is fast, widely available, and excellent at detecting acute intracranial hemorrhage. If no bleed is seen and there are no contraindications, thrombolysis can proceed within the approved time window.

MRI can provide more sensitive information about early brain injury and can map tissue viability with diffusion and perfusion imaging. In selected cases—such as when the onset time is uncertain, in wake-up strokes, or when CT results are inconclusive—MRI can help refine treatment decisions. However, it typically requires more time and resources, which can delay therapy in the emergency setting, so it is not the standard modality used to guide thrombolysis in most acute protocols.

Ultrasound and X-ray don’t provide the necessary rapid, whole-brain assessment needed to guide thrombolytic therapy decisions in acute stroke. Ultrasound mainly adds vascular information and is not used alone to decide about thrombolysis, and X-ray offers limited brain detail relevant to this decision.

So, while MRI has important roles in comprehensive stroke evaluation, the standard imaging choice to guide thrombolysis in the acute window is non-contrast CT, with MRI used selectively in specific scenarios.